Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: Follow-up for up to 28 years

Gastroenterology

Volumn 123, Issue 4, 2002, Pages 1044-1051

  Prince, Martin ^a   Chetwynd, Amanda ^b   Newman, Wendy ^a   Metcalf, Jane V ^a   James, Oliver F W ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; BILIRUBIN;

ADULT; AGE; AGED; ARTICLE; ASCITES; BONE PAIN; DEATH CERTIFICATE; DISEASE COURSE; FATIGUE; FEMALE; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HUMAN; INTERVIEW; JAUNDICE; KAPLAN MEIER METHOD; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; PRURITUS; SURVIVAL; SYMPTOMATOLOGY;

EID: 0036787339     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.36027     Document Type: Article

References (42)

1. Kaplan M. Primary biliary cirrhosis. N Engl J Med 1996;335: 1570-1580.
2. Ahrens E, Payne M, Kunkel H, Eisenmenger E, Blondheim S. Primary biliary cirrhosis. Medicine 1950;29:299-366.
3. Sherlock S. Primary biliary cirrhosis (chronic intrahepatic obstructive jaundice). Gastroenterology 1959;37:574-586.
4. Witt-Sullivan H, Heathcote J, Cauch K, Blendis L, Ghent C, Katz A, Milner R, Pappas SC, Rankin J, Wanless IR. The demography of primary biliary cirrhosis in Ontario, Canada. Hepatology 1990;12: 98-105.
5. Nyberg A, Loof L. Primary biliary cirrhosis: clinical features and outcome, with special reference to asymptomatic disease. Scand J Gastroenterol 1989;24:57-64.
6. Mitchison HC, Lucey MR, Kelly PJ, Neuberger JM, Williams R, James OF. Symptom development and prognosis in primary biliary cirrhosis: a study in two centers. Gastroenterology 1990;99: 778-784.
7. Mahl TC, Shockcor W, Boyer JL. Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years. J Hepatol 1994;20:707-713.
8. James O, Macklon AF, Watson AJ. Primary biliary cirrhosis-a revised clinical spectrum. Lancet 1981;1:1278-1281.
9. Eriksson S, Lindgren S. The prevalence and clinical spectrum of primary biliary cirrhosis in a defined population. Scand J Gastroenterol 1984;19:971-976.
10. Crowe J, Christensen E, Doniach D, Popper H, Tygstrup N, Williams R. Early features of primary biliary cirrhosis: an analysis of 85 patients. Am J Gastroenterol 1985;80:466-468.
11. Christensen E, Crowe J, Doniach D, Popper H, Ranek L, Rodes J, Tygstrup N, Williams R. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. Gastroenterology 1980;78:236-246.
12. Beswick DR, Klatskin G, Boyer JL. Asymptomatic primary biliary cirrhosis. A progress report on long-term follow-up and natural history. Gastroenterology 1985;89:267-271.
13. James OF, Bhopal R, Howel D, Gray J, Burt AD, Metcalf JV. Primary biliary cirrhosis once rare, now common in the United Kingdom? Hepatology 1999;30:390-394.
14. Ray-Chadhuri D, Rigney E, McComack K, Trudhill N, Dube A, Millford-Ward A, Gleeson D. Epidemiology of PBC in Sheffield updated: demographics and relation to water supply. Annual Meeting of the British Association for the Study of the Liver, London, England, 2001.
15. Kingham JG, Parker DR. The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut 1998;42:120-122.
16. Steinke D, Weston T, Morris A, Macdonald T, Dillon J. Incidence, prevalence and resource use of primary biliary cirrhosis in Tayside, Scotland (abstr). J Hepatol 2001;31:532A.
17. Kim WR, Lindor KD, Locke GR III, Therneau TM, Homburger HA, Batts KP, Yawn BP, Petz JL, Melton LJ III, Dickson ER. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology 2000;119:1631-1636.
18. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1989;10:1-7.
19. Grambsch PM, Dickson ER, Kaplan M, LeSage G, Fleming TR, Langworthy AL. Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizability. Hepatology 1989;10:846-850.
20. Neuberger J. Transplantation for primary biliary cirrhosis. Semin Liver Dis 1997;17:137-146.
21. Goulis J, Leandro G, Burroughs AK. Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. Lancet 1999;354:1053-1060.
22. Gluud C, Christensen E. Ursodeoxycholic acid for primary biliary cirrhosis: lesson for the future? J Hepatol 2001;34:787-788.
23. Kieding N. Independent delayed entry. In: Goel PK, Klein JP, eds. Proceedings of the NATO advanced statistics workshop on survival analysis and related topics. Columbus, OH: Kluwer Academic, 1991:309-326.
24. Schemper M, Stare A. Explained variation in survival. Stat Med 1996;15:1999-2012.
25. Maddala G. Limited dependent and qualitative variables in econometrics. New York, NY: Cambridge University Press, 1983.
26. Parmar M, Machin D. Survival analysis: a practical approach. New York, NY: Wiley, 1995.
27. Prince M, Jones D, Metcalf J, Craig W, James O. Symptom development and prognosis of initially asymptomatic PBC (abstr). Hepatology 2000;32:171A.
28. Cauch-Dudek K, Abbey S, Stewart DE, Heathcote EJ. Fatigue in primary biliary cirrhosis. Gut 1998;43:705-710.
29. Prince M, James O, Jones D. Fatigue in patients with primary biliary cirrhosis: validation of fatigue severity score as a clinical and research tool (abstr). Hepatology 1998;28:542A.
30. Parikh-Patel A, Gold EB, Worman H, Krivy KE, Gershwin ME. Risk factors for primary biliary cirrhosis in a cohort of patients from the United States. Hepatology 2001;33:16-21.
31. Howel D, Fischbacher C, Bhopal R, Gray J, Metcalf J, James O. An exploratory population-based case-control study of primary biliary cirrhosis. Hepatology 2000;31:1055-1060.
32. Crippin JS, Lindor KD, Jorgensen R, Kottke BA, Harrison JM, Murtaugh PA, Dickson ER. Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk? Hepatology 1992;15:858-862.
33. Nijhawan PK, Therneau TM, Dickson ER, Boynton J, Lindor KD. Incidence of cancer in primary biliary cirrhosis: the Mayo experience. Hepatology 1999;29:1396-1398.
34. Wolke AM, Schaffner F, Kapelman B, Sacks HS. Malignancy in primary biliary cirrhosis. High incidence of breast cancer in affected women. Am J Med 1984;76:1075-1078.
35. Loof L, Adami HO, Sparen P, Danielsson A, Eriksson LS, Hultcrantz R, Lindgren S, Olsson R, Prytz H, Ryden BO. Cancer risk in primary biliary cirrhosis: a population-based study from Sweden. Hepatology 1994;20:101-104.
36. Goudie BM, Burt AD, Boyle P, Macfarlane G, Birnie GG, Mills PR, Gillis CR, MacSween RN, Watkinson G. Breast cancer in women with primary biliary cirrhosis. BMJ 1985;291:1597-1598.
37. Howel D, Metcalf JV, Gray J, Newman WL, Jones DE, James OF. Cancer risk in primary biliary cirrhosis: a study in northern England. Gut 1999;45:756-760.
38. Christensen E, Altman DG, Neuberger J, De Stavola BL, Tygstrup N, Williams R. Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. PBC1 and PBC2 trial groups. Gastroenterology 1993;105:1865-1876.
39. Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R, Heathcote EJ. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997;113:884-890.
40. Heathcote EJ. Management of primary biliary cirrhosis. Hepatology 2000;31:1005-1015.
41. Kilmurry MR, Heathcote EJ, Cauch-Dudek K, O'Rourke K, Bailey RJ, Blendis LM, Ghent CN, Minuk GY, Pappas SC, Scully LJ, Steinbrecher UP, Sutherland LR, Williams CN, Worobetz LJ. Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis? Hepatology 1996;23:1148-1153.
42. Angulo P, Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M, Kamath PS, Dickson ER. Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid. Liver 1999;19:115-121.